Performance of Premarket Rapid Hepatitis C Virus Antibody Assays in 4 National Human Immunodeficiency Virus Behavioral Surveillance System Sites | Zendy

Bryce D. Smith | Zendy; Eyasu H. Teshale | Zendy; Amy Jewett | Zendy; Cindy M. Weinbaum | Zendy; Alan Neaigus | Zendy; Holly Hagan | Zendy; Samuel M. Jenness | Zendy; Sharon Melville | Zendy; Richard K. Burt | Zendy; Hanne Thiede | Zendy; Alia AlTayyib | Zendy; P. R. Pannala | Zendy; Isa Miles | Zendy; Alexandra M. Oster | Zendy; Amanda Smith | Zendy; Teresa Finlayson | Zendy; Kristina Bowles | Zendy; Elizabeth DiNenno | Zendy

Open Access

Performance of Premarket Rapid Hepatitis C Virus Antibody Assays in 4 National Human Immunodeficiency Virus Behavioral Surveillance System Sites

Author(s) -

Bryce D. Smith,

Eyasu H. Teshale,

Amy Jewett,

Cindy M. Weinbaum,

Alan Neaigus,

Holly Hagan,

Samuel M. Jenness,

Sharon Melville,

Richard K. Burt,

Hanne Thiede,

Alia AlTayyib,

P. R. Pannala,

Isa Miles,

Alexandra M. Oster,

Amanda Smith,

Teresa Finlayson,

Kristina Bowles,

Elizabeth DiNenno

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir499

Subject(s) - medicine , virology , antibody , human immunodeficiency virus (hiv) , virus , hepatitis c virus , hepatitis a virus , viral disease , immunology

Performance characteristics of rapid assays for hepatitis C virus antibody were evaluated in 4 National HIV Behavioral Surveillance System injection drug use sites. The highest assay-specific sensitivities achieved for the Chembio, MedMira and OraSure tests were 94.0%, 78.9%, and 97.4%, respectively; the highest specificities were 97.7%, 83.3%, and 100%, respectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research